Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CBSC NASDAQ:ICU NASDAQ:NRXS NYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCBSCCardiac Biotech Solutions$0.04+5.3%$0.04$0.02▼$0.15$6.62M1.1460,557 shs33,750 shsICUSeaStar Medical$0.84-3.3%$0.77$0.31▼$5.22$23.51M-13.02 million shs878,529 shsNRXSNeurAxis$2.34-3.3%$2.52$1.33▼$6.20$23.10M3.1604,765 shs28,171 shsRVPRetractable Technologies$0.82-0.5%$0.76$0.56▼$0.93$24.43M1.458,268 shs38,952 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCBSCCardiac Biotech Solutions0.00%+5.26%+6.67%-0.50%0.00%ICUSeaStar Medical0.00%+9.50%+8.26%-20.16%-82.22%NRXSNeurAxis0.00%-0.21%+0.62%-3.77%-18.35%RVPRetractable Technologies0.00%+3.76%+3.37%+23.96%-9.67%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCBSCCardiac Biotech Solutions$0.04+5.3%$0.04$0.02▼$0.15$6.62M1.1460,557 shs33,750 shsICUSeaStar Medical$0.84-3.3%$0.77$0.31▼$5.22$23.51M-13.02 million shs878,529 shsNRXSNeurAxis$2.34-3.3%$2.52$1.33▼$6.20$23.10M3.1604,765 shs28,171 shsRVPRetractable Technologies$0.82-0.5%$0.76$0.56▼$0.93$24.43M1.458,268 shs38,952 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCBSCCardiac Biotech Solutions0.00%+5.26%+6.67%-0.50%0.00%ICUSeaStar Medical0.00%+9.50%+8.26%-20.16%-82.22%NRXSNeurAxis0.00%-0.21%+0.62%-3.77%-18.35%RVPRetractable Technologies0.00%+3.76%+3.37%+23.96%-9.67%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCBSCCardiac Biotech Solutions 0.00N/AN/AN/AICUSeaStar Medical 0.00N/AN/AN/ANRXSNeurAxis 3.00Buy$7.00199.15% UpsideRVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CBSC, ICU, RVP, and NRXS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/16/2025NRXSNeurAxisCraig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy$7.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCBSCCardiac Biotech Solutions$140K47.27N/AN/AN/A∞ICUSeaStar Medical$140K167.92N/AN/A($0.34) per share-2.48NRXSNeurAxis$3.22M7.18N/AN/A($0.27) per share-8.67RVPRetractable Technologies$38.16M0.64$0.02 per share48.25$3.31 per share0.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCBSCCardiac Biotech SolutionsN/AN/A0.00∞N/AN/AN/AN/AN/AICUSeaStar Medical-$24.83M-$2.62N/A∞N/A-1,915.27%N/A-232.65%11/11/2025 (Estimated)NRXSNeurAxis-$14.63M-$0.99N/A∞N/A-492.76%N/A-641.25%N/ARVPRetractable Technologies-$7.01M-$0.29N/A∞N/A-41.11%-17.15%-9.33%N/ALatest CBSC, ICU, RVP, and NRXS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025ICUSeaStar Medical-$0.43-$0.18+$0.25-$0.18$0.25 million$0.34 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCBSCCardiac Biotech SolutionsN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/ANRXSNeurAxisN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCBSCCardiac Biotech SolutionsN/AN/AN/AICUSeaStar MedicalN/A1.521.50NRXSNeurAxisN/A0.240.23RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCBSCCardiac Biotech SolutionsN/AICUSeaStar Medical1.69%NRXSNeurAxis11.77%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipCBSCCardiac Biotech SolutionsN/AICUSeaStar Medical1.30%NRXSNeurAxis26.40%RVPRetractable Technologies57.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCBSCCardiac Biotech Solutions5165.44 millionN/ANot OptionableICUSeaStar Medical227.92 million27.55 millionNot OptionableNRXSNeurAxis199.87 million6.09 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableCBSC, ICU, RVP, and NRXS HeadlinesRecent News About These CompaniesHead-To-Head Contrast: Retractable Technologies (NYSE:RVP) versus Minerva Surgical (NASDAQ:UTRS)September 10, 2025 | americanbankingnews.comRetractable Technologies (NYSE:RVP) vs. Motus GI (NASDAQ:MOTS) Financial ComparisonSeptember 9, 2025 | americanbankingnews.comRetractable Technologies Stock Gains Following Q2 Earnings GrowthAugust 21, 2025 | zacks.comInsider Buying: Retractable Technologies (NYSE:RVP) CEO Acquires 32,935 Shares of StockAugust 20, 2025 | insidertrades.comRetractable Technologies Reports Q2 2025 Financial ResultsAugust 14, 2025 | msn.comRetractable Technologies, Inc. Results for the Periods Ended June 30, 2025August 14, 2025 | businesswire.comRetractable Technologies, Inc. (NYSE:RVP) CEO Purchases $37,155.75 in StockAugust 12, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $20,193.12 in StockAugust 1, 2025 | insidertrades.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce | RVP Stock NewsJuly 23, 2025 | gurufocus.comRetractable Technologies, Inc. Announces Reduction in Its Manufacturing WorkforceJuly 23, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Business WireJuly 2, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersJune 30, 2025 | businesswire.comRetractable technologies CEO Shaw buys $14,274 in RVP stockJune 20, 2025 | investing.comZacks Initiates Coverage of Retractable Technologies With Underperform RecommendationJune 19, 2025 | zacks.comRetractable Technologies, Inc. (NYSE:RVP) CEO Buys $14,313.42 in StockJune 19, 2025 | insidertrades.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $13,047.54 in StockJune 17, 2025 | insidertrades.comretractable technologies appoints new auditor after mergerJune 8, 2025 | investing.comThomas J. Shaw Buys 86,014 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockMay 17, 2025 | insidertrades.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025 | RVP Stock NewsMay 15, 2025 | gurufocus.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025May 15, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCBSC, ICU, RVP, and NRXS Company DescriptionsCardiac Biotech Solutions OTCMKTS:CBSC$0.04 +0.00 (+5.26%) As of 10:47 AM EasternCB Scientific, Inc., through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.SeaStar Medical NASDAQ:ICU$0.84 -0.03 (-3.25%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.NeurAxis NASDAQ:NRXS$2.34 -0.08 (-3.31%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.Retractable Technologies NYSE:RVP$0.82 0.00 (-0.49%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
